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Bisphosphonates (BPs) are a family of drugs that are successfully used in the treatment 
of various calcium-related disorders such as Paget´s disease, osteoporosis and bone 
metastases. In addition, functional BPs have been also used in the treatment of metal 
intoxication and as novel ligands for well-defined radioactive metal complexes that can 
be used in imagiology, scintigraphy and radiotherapy applications [1,2]. 
The indazole derivatives are pharmacologically important compounds and the indazole 
ring system forms the basis of a number of drug molecules. Condensed pyrazoles are 
also known as pharmacophoric elements in numerous active compounds. However, in 
comparison with other heteroaromatic compounds, the chemistry of indazole and 
condensed pyrazoles remains less studied [3].  
The present work is to extend the previous studies in indazolebisphosphonates [4] in 
order to obtain new BPs derived from indazole and condensed pyrazole with potential 
biological/therapeutical activities. Herein, we report the synthesis and characterization 
of a series of new 1-hydroxybisphosphonates (1) and aminobisphosphonates (2) 
(substituted at different C- or N-positions of the indazole ring - N-1, C-5, C-6, C-7) 
(Figure 1). Crystal structure of an aminobisphosphonate was determined by X-ray 
crystallography. 
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